India's One of the Women Entrepreneur Led Biotechnology Company's New Biosimilar in U.S. Gains Access to Over 100 Million Lives India's One of the Women Entrepreneur Led Biotechnology Company's New Biosimilar in U.S. Gains Access to Over 100 Million Lives The has given modest returns of 4.41 per cent over the past year. However, it has declined by 11.93 per cent over the last three years. DSIJ Intelligence-2 / Monday, May 5, 2025 0 176 Article rating: 4.1 The has given modest returns of 4.41 per cent over the past year. However, it has declined by 11.93 per cent over the last three years. Read more
Kiran Mazumdar Shaw-Backed Pharma Company is Likely to Raise Funds by Way of Issue of Equity Shares Kiran Mazumdar Shaw-Backed Pharma Company is Likely to Raise Funds by Way of Issue of Equity Shares The company has been maintaining a healthy dividend payout of 18 per cent. DSIJ Intelligence-1 / Sunday, April 20, 2025 0 484 Article rating: 3.7 The company has a market cap of Rs 39,728 crore where Kiran Mazumdar Shaw (promoter of the company) holds a 40.36 per cent stake in the company. Read more
Sensex Gains 300 Points, Nifty Crosses 200-DEMA; PSU Banks Outperform Sensex Gains 300 Points, Nifty Crosses 200-DEMA; PSU Banks Outperform Market breadth indicators show that 54 stocks touched their 52-week highs, whereas only 11 stocks hit their 52-week lows. DSIJ Intelligence-2 / Wednesday, April 16, 2025 0 138 Article rating: 5.0 Read more
Sensex and Nifty Jump After Long Weekend on Global Cues Sensex and Nifty Jump After Long Weekend on Global Cues Broader indices, including small-cap and mid-cap stocks, moved up, gaining 1.3 per cent each. DSIJ Intelligence-2 / Tuesday, April 15, 2025 0 112 Article rating: 2.0 Read more
The Indian Biotech Leader Expands its Operations in the U.S. Strategically Through the Launch of a New Biosimilar The Indian Biotech Leader Expands its Operations in the U.S. Strategically Through the Launch of a New Biosimilar Over the past year, Biocon delivered a return of 15.51 per cent, while its three-year return stood at -9.75 per cent. DSIJ Intelligence-2 / Tuesday, April 15, 2025 0 181 Article rating: 5.0 Over the past year, Biocon delivered a return of 15.51 per cent, while its three-year return stood at -9.75 per cent. Read more